After Hours Summary: TBPH +25.7% and INVA +9.6% jump on deal to sell Trelegy assets; AZTA -11% falls on weak guidance; NVAX -0.9% vaccine gets approvedAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: None
Companies trading higher in after hours in reaction to news: TBPH +25.7% (TBPH to sell all of its units in Theravance Respiratory to RPRX for over $1.5 bln), INVA +9.6% (INVA sells its 15% economic stake in Theravance to RPRX for $282 mln), GRBK +7.7% (to join S&P SmallCap 600), VCTR +2.8% (reports June AUM), HASI +2.5% (responds to Muddy Waters shor report), ANGI +2% (report June performance metrics), HTA +1.9% (to join S&P MIdCap 400 following its acquisition of HR), HIVE +1.9% (expects to complete its annual filings on or before July 18), EGO +1.7% (announces Q2 preliminary gold production), RC +1.2% (forms new JV to originate circa €300m of new commercial real estate loans), ESTC +0.5% (announces enhancements to its cross-cluster search and replication capabilities), WBA +0.2% (increases dividend), MN +0.1% (reports June AUM)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: AZTA -11% (lowers guidance for JunQ revs), HMN -4.8% (trims its FY22 earnings guidance), WELL -0.2%, WAFD -0.1%
Companies trading lower in after hours in reaction to news: CFRX -77.2% (independent DSMB recommends Exebacase Phase 3 DISRUPT Study be stopped), BLU -6.5% (stock offering), COKE -2.5% (to move to S&P MidCap 400 from SmallCap 600), FLYW -1.8% (acquires Cohort Go), NVAX -0.9% (FDA authorizes NVAX's COVID-19 vaccine for adults), RPRX -0.8% (TBPH to sell all of its units in Theravance Respiratory to RPRX for over $1.5 bln; also INVA sells its 15% economic stake in Theravance to RPRX for $282 mln), BRDG -0.5% (expands into solar energy via partnership with Lumen Energy), TSLA -0.5% (Tesla Autopilot exec to step down), WDAY -0.3% (achieves FedRAMP authorized status at the Moderate level), MOH -0.3% (to acquire My Choice Wisconsin for $150 mln)